CAZypedia needs your help! We have many unassigned GH, PL, CE, AA, GT, and CBM pages in need of Authors and Responsible Curators.
Scientists at all career stages, including students, are welcome to contribute to CAZypedia. Read more here, and in the 10th anniversary article in Glycobiology.
New to the CAZy classification? Read this first.
*
Consider attending the 15th Carbohydrate Bioengineering Meeting in Ghent, 5-8 May 2024.
Difference between revisions of "User:Ana Luis"
Harry Brumer (talk | contribs) |
|||
| Line 1: | Line 1: | ||
[[Image:Blank_user-200px.png|200px|right]] | [[Image:Blank_user-200px.png|200px|right]] | ||
| − | |||
| − | + | I obtained a M.Sc in Pharmaceutical Sciences at University of Lisbon in 2009. After I worked with Dr. Carlos Fontes at Technical University of Lisbon, studying the mechanisms of protein-carbohydrate interactions. Currently, I'm doing the PhD under the supervision of Prof. Harry Gilbert at Newcastle University. My research has focus on functional and structural characterization of enzymes and carbohydrate binding modules. I'm also interested in understanding the mechanisms behind the pectins degradation and utilization by intestinal bacteria. | |
| − | + | I contributed to structural-functional characterization of CBM65 ('''Family first''') <cite>Luis2013</cite> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | '' | ||
| Line 16: | Line 8: | ||
<biblio> | <biblio> | ||
| − | # | + | #Luis2013 pmid=23229556 |
</biblio> | </biblio> | ||
Revision as of 12:02, 4 October 2015
I obtained a M.Sc in Pharmaceutical Sciences at University of Lisbon in 2009. After I worked with Dr. Carlos Fontes at Technical University of Lisbon, studying the mechanisms of protein-carbohydrate interactions. Currently, I'm doing the PhD under the supervision of Prof. Harry Gilbert at Newcastle University. My research has focus on functional and structural characterization of enzymes and carbohydrate binding modules. I'm also interested in understanding the mechanisms behind the pectins degradation and utilization by intestinal bacteria. I contributed to structural-functional characterization of CBM65 (Family first) [1]
- Luís AS, Venditto I, Temple MJ, Rogowski A, Baslé A, Xue J, Knox JP, Prates JA, Ferreira LM, Fontes CM, Najmudin S, and Gilbert HJ. (2013). Understanding how noncatalytic carbohydrate binding modules can display specificity for xyloglucan. J Biol Chem. 2013;288(7):4799-809. DOI:10.1074/jbc.M112.432781 |